Detalhe da pesquisa
1.
Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy.
Blood
; 141(6): 609-619, 2023 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36351239
2.
Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy.
Blood
; 139(14): 2173-2185, 2022 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34871373
3.
Pediatric Hematopoietic Stem Cell Transplant.
Pediatr Rev
; 41(11): 609-611, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33139417
4.
TPMT and MTHFR genotype is not associated with altered risk of thioguanine-related sinusoidal obstruction syndrome in pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Pediatr Blood Cancer
; 61(11): 2086-8, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24737678
5.
Reduced toxicity matched sibling bone marrow transplant results in excellent outcomes for severe congenital neutropenia.
Front Immunol
; 15: 1369243, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38469307
6.
Reinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemia.
Blood Adv
; 8(9): 2182-2192, 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38386999
7.
Evaluation of Children with Malignancies for Blood and Marrow Transplantation: A Report from the ASTCT Committee on Practice Guidelines.
Transplant Cell Ther
; 29(5): 293-301, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36775202
8.
Unrelated donor α/ß T cell- and B cell-depleted HSCT for the treatment of pediatric acute leukemia.
Blood Adv
; 6(4): 1175-1185, 2022 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34872106
9.
CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials.
Lancet Haematol
; 8(10): e711-e722, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34560014
10.
Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial.
J Clin Oncol
; 39(8): 920-930, 2021 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33417474
11.
Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia.
J Clin Oncol
; 39(27): 3044-3055, 2021 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34156874
12.
Drug-metabolizing enzyme polymorphisms predict clinical outcome in a node-positive breast cancer cohort.
J Clin Oncol
; 23(24): 5552-9, 2005 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-16110016
13.
Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer.
Cancer Res
; 63(22): 8051-6, 2003 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-14633738
14.
Ethnic disparities in adjuvant chemotherapy for breast cancer are not caused by excess toxicity in black patients.
Clin Breast Cancer
; 6(3): 260-6; discussion 267-9, 2005 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16137438
15.
Associations between genetic variants in folate and drug metabolizing pathways and relapse risk in pediatric acute lymphoid leukemia on CCG-1952.
Leuk Res Rep
; 4(2): 47-50, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26605150